Combined Modality Therapy for Multiple Myeloma, VMCP-VBAP for Remission Induction Therapy: VMCP vs. Sequential Half-Body Radiotherapy + Vincristine-Prednisone for Maintenance or Consolidation. Evaluation of Half-body Radiotherapy + Vincristine-Prednisone for patients Who Fail to Achieve Remission Status with Chemotherapy Alone

Magnitude of response with myeloma frontline therapy does not predict outcome: importance of time to progression in Southwest Oncology Group chemotherapy trials

BGM Durie;J Jacobson;B Barlogie;J Crowley Journal of Clinical Oncology 22(10):1857-1863

A new staging system for multiple myeloma patients based on the Southwest Oncology Group (SWOG) experience

JL Jacobson;MA Hussein;B Barlogie;BGM Durie;JJ Crowley British Journal of Haematology 122:441-450

Partitioning and peeling for constructing prognostic groups

M LeBlanc;J Jacobson;J Crowley Statistical Methods in Medical Research 11:247-274

Standard-dose therapy for multiple myeloma: the Southwest Oncology Group experience

J Crowley;J Jacobson;R Alexanian Seminars in Hematology 38(3):203-208

Adaptive regression splines in the cox model

M LeBlanc;J Crowley Biometrics 55:204-213

Some exploratory tools for survival analysis.

J Crowley;M LeBlanc;J Jacobson;SE Salmon In Lecture Notes In Statistics :199-229

Evaluation of race as a prognostic factor in multiple myeloma: An ancillary of Southwest Oncology Group study 8829.

MR Modiano;P Villar-Werstler;J Crowley;SE Salmon Journal of Clinical Oncology 14(3):974-977

A review of tree-based prognostic models.

M LeBlanc;J Crowley Recent Advances in Clinical Trial Design and Analysis :113-124

Step-function covariate effects in the proportional-hazards model.

M LeBlanc;J Crowley The Canadian Journal of Statistics 23(2):109-129

Exploratory methods in survival analysis.

J Crowley;M LeBlanc;R Gentleman;S Salmon IMS Lecture Notes - Monograph Series 27:55-77

Prognostic correlation of plasma cell acid phosphatase and B-Glucuronidase in multiple myeloma: A Southwest Oncology Group study.

SM Saeed;D Stock-Novack;R Pohlod;J Crowley;SE Salmon Blood 78(12):3281-3287

Prognostic value of pretreatment serum B2 microglobulin in myeloma: A Southwest Oncology Group study.

BGM Durie;D Stock-Novack;SE Salmon;P Finley;J Beckord;J Crowley;C Coltman, Jr Blood 75(4):823-830

Chemotherapy is superior to sequential hemibody irradiation for remission consolidation in multiple myeloma: A Southwest Oncology Group study.

SE Salmon;D Tesh;J Crowley;S Saeed;P Finley;MS Milder;LF Hutchins;C Coltman, Jr;JD Bonnet;B Cheson;JA Knost;A Samhouri;J Beckord;D Stock-Novack JCO 8(9):1575-1584

Immaturity and dyspoiesis scoring: A system to discriminate benign vs. malignant plasmacytic proliferation.

SM Saeed;BKS Raman;R Pohlod Modern Pathology 3:1(514)

Combination chemotherapy is superior to hemibody irradiation(HXRT) for remission consolidation in multiple myeloma (MM): A Southwest Oncology Group (SWOG) study.

S Salmon;D Tesh;J Crowley;S Saeed;P Finley;D Stock-Novack ASCO 8:250(#975)